All Posts By

Smartkarma Daily Briefs

Daily Brief ECM: Everest Medicine Placement – Third Deal in the Year and more

By | Daily Briefs, ECM

In today’s briefing:

  • Everest Medicine Placement – Third Deal in the Year, Previous Ones Didn’t Do Well
  • OSL Group Placement: Momentum Is Strong but Is Opportunistic
  • Leads Biolabs (维立志生物) Trading Update
  • Brigade Hotel IPO: Not Suited for a Long Term Stay for Now, Can Try For a Quick Day Trip Gain
  • McGraw Hill, Inc. (MH): Another Private Equity Backed IPO Trades Below Issue, Closes Flat
  • Aux Electric Co Ltd Pre-IPO Tearsheet
  • Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO
  • Accelerant Holdings (ARX): Insurance Sector Brings Another IPO Winner to Market; Pops 36% at Open
  • Kasumigaseki REIT Pre-IPO: Peer Comparison – Small Is Size but Matching Its Peers on Other Metrics


Everest Medicine Placement – Third Deal in the Year, Previous Ones Didn’t Do Well

By Sumeet Singh

  • Everest Medicines (1952 HK) aims to raise around US$200m via a top-up placement.
  • This will be the third placement this year for the stock, the previous two deals didn’t do well. Although the stock has bounced back a lot since.
  • In this note, we comment on the deal dynamics and run the deal through our ECM framework.

OSL Group Placement: Momentum Is Strong but Is Opportunistic

By Nicholas Tan

  • BC Technology Group (863 HK) is looking to raise around US$157m from a primary placement.
  • The deal is a large one to digest, representing 20.2 days of the stock’s three month ADV, and 11.3% of total shares outstanding.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Leads Biolabs (维立志生物) Trading Update

By Ke Yan, CFA, FRM

  • Leads Biolabs raised HKD 1290m (USD 166m) from its global offering and will list on the Hong Kong Stock Exchange on Friday, July 24th.
  • In our previous note, we looked at the company’s operation, management track records and discussed the IPO valuation.
  • In this note, we provide an update for the IPO before trading debut.

Brigade Hotel IPO: Not Suited for a Long Term Stay for Now, Can Try For a Quick Day Trip Gain

By Tina Banerjee

  • Brigade Hotel Ventures has filed for IPO to raise up to INR 7,596M. The company plans to sell 84.4M shares at between INR 85 and INR 90 per share.
  • The company owns and develops hotels in key cities in India, with a portfolio of nine operating hotels. The hotels are operated by global marquee hospitality companies.
  • The debt-to-equity ratio for Brigade Hotel being at 5.8x is the highest among its peers. The company’s plans to use the proceeds to service the outstanding debts makes sense.

McGraw Hill, Inc. (MH): Another Private Equity Backed IPO Trades Below Issue, Closes Flat

By IPO Boutique

  • McGraw Hill (MH US) priced a full-size offering of 24.4mm shares at $17.00 and saw a flat opening print. 
  • This was the second private equity backed deal of the week and second to trade below issue.
  • Ultimately, the deal did not have the “strength” and was forced to give-way to the buy-side with a $2 discount below the low-end of the range.

Aux Electric Co Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Aux Electric Co Ltd (0917839D HK)  (AECL) is looking to raise about US$100m in its upcoming Hong Kong IPO. The bookrunners for the deal are CICC and Oriental Securities.
  • AECL is engaged in the design, R&D, manufacturing, sales, and after-sales services of both household and central air conditioners, with operations spanning over 150 countries and regions.
  • According to F&S Report, AECL was among the top five global air conditioner providers by sales volume in 2024, with a market share of 7.1%.

Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO

By IPO Boutique

  • Shoulder Innovations will be offering 5.0mm shares at $19-$21 and to debut on July 31st.
  • The underwriters have reserved up to 6% of the shares of common stock offered through a directed share program. 
  • The sector had a surprise underperformance from CarlsMed this week and will be looking to rebound with this upcoming IPO. 

Accelerant Holdings (ARX): Insurance Sector Brings Another IPO Winner to Market; Pops 36% at Open

By IPO Boutique

  • Accelerant Holdings (ARX US)  priced 34.46mm shares (upsized from 28.95mm) at $21.00($1 Above the $18-$20 range) and opened at $28.50 for a gain of 35.7% at first trade.
  • This was the fifth insurance related IPO to debut in 2025 and all have been winners.
  • We see this company having potential staying power in the short term. Several insurance related IPOs have traded higher for longer than many short term investors would have anticipated.

Kasumigaseki REIT Pre-IPO: Peer Comparison – Small Is Size but Matching Its Peers on Other Metrics

By Nicholas Tan


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: West China Cement, SK Hynix
  • US treasuries fell yesterday, with yields rising after three straight days of declines. That said, the sell-off in longer-dated treasuries moderated during the day, following strong demand for an auction of 20Y notes.
  • The UST curve bear-flattened, with the yield on the 2Y UST rising 5 bps to 3.88%, while the yield on the 10Y UST was up 4 bps at 4.38%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: QAF: Regional Consumer Stock with Appealing 5.6% Dividend Yield and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • QAF: Regional Consumer Stock with Appealing 5.6% Dividend Yield
  • Tesla (TSLA): Go Short
  • Corpay’s $2.2 Billion Move: Why The Alpha Group Deal Could Be A Game-Changer For Global B2B Payments
  • Fisher & Paykel Healthcare (FPH AU) Vs. ResMed (RMD AU): Dislocation in Healthcare
  • SK Hynix: Good 2Q, Positive Messages but No 2026 Guidance Means that Market’s Doubts Will Remain
  • Palo Alto Eyes SentinelOne: The $7 Billion Power Move That Could Reshape Cybersecurity!
  • Deere & Co Is Quietly Dominating the AI Farming Revolution—Here’s Why It Could Be The TESLA Of Agriculture!
  • Datadog Eyes $1 Billion Upwind Deal: Could This Be A Game-Changer For Cloud Security?
  • [Earnings Preview] Shell Falters on Fundamentals, But Options Data Signals Optimism
  • Dialogue. Evolution 2Q25 Business Update, Black Markets, UK Investigation, Asia Cyber Attacks


QAF: Regional Consumer Stock with Appealing 5.6% Dividend Yield

By Punit Khanna

  • Singapore small-mid cap stocks are having a good run in anticipation of Market Equity Development Programme. QAF may appeal to yield investors
  • QAF is a well run number 1 bread company in Singapore, Malaysia and Philippines
  • Business is stable and mature making it difficult for a new player to enter the market

Tesla (TSLA): Go Short

By Henry Soediarko

  • Not impressive earnings result for 2Q25 as revenue fell 12%, led by a weaker EV sales followed by lower sales from the renewable energy division as well.  
  • The highest-margin business contributor, regulatory credit, may be gone soon as recently the US government removed the financial penalty for higher emissions. 
  • Tesla (TSLA US) is trading at premium compared to its Chinese counterparts such as BYD (1211 HK) , NIO (9866 HK) and XPeng (9868 HK) .

Corpay’s $2.2 Billion Move: Why The Alpha Group Deal Could Be A Game-Changer For Global B2B Payments

By Baptista Research

  • Corpay has made headlines with its definitive agreement to acquire Alpha Group International in an all-cash deal valued at approximately $2.2 billion (£1.6 billion).
  • The transaction, offering Alpha shareholders £42.50 per share—a 55% premium over its undisturbed price as of May 1, 2025—is expected to close in Q4 2025, pending shareholder and regulatory approvals.
  • This acquisition comes on the heels of a busy strategic year for Corpay, including a $300 million cross-border partnership with Mastercard and a minority investment in AvidXchange.

Fisher & Paykel Healthcare (FPH AU) Vs. ResMed (RMD AU): Dislocation in Healthcare

By Gaudenz Schneider

  • Context: The Fisher & Paykel Healthcare (FPH AU) vs. ResMed (RMD AU) Price-Ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: The long position is supported by higher growth aligning well with the statistical analysis. The trade faces some event risk due to an upcoming earnings announcement.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

SK Hynix: Good 2Q, Positive Messages but No 2026 Guidance Means that Market’s Doubts Will Remain

By Nicolas Baratte

  • 2Q25 beats consensus by 5% with a number of unexpected moves: NAND and Commodity DRAM shipments a lot higher than expected, hence weaker ASP (more commodity), margins decline QoQ. 
  • HBM positive messages: HBM sales double in 2025, we now have secured visibility on next year’s demand”, leading to higher capex in 2025, HBM will continue to enjoy strong growth. 
  • But a lack of concrete numbers (HBM, eSSD % of revenue), 2025-26 Capex, capacity increase, etc means that the market will not find grounds to have a more positive view. 

Palo Alto Eyes SentinelOne: The $7 Billion Power Move That Could Reshape Cybersecurity!

By Baptista Research

  • Rumors are swirling around a potential acquisition that could significantly reshape the cybersecurity landscape.
  • SentinelOne, a company known for its autonomous endpoint protection platform, saw its shares surge after reports emerged suggesting that industry giant Palo Alto Networks (NASDAQ: PANW) might be in advanced talks to acquire it.
  • While neither company has confirmed the speculation, multiple Israeli media outlets have cited industry sources suggesting a potential deal value of around $7 billion.

Deere & Co Is Quietly Dominating the AI Farming Revolution—Here’s Why It Could Be The TESLA Of Agriculture!

By Baptista Research

  • Deere & Co is no longer just a symbol of tractors and green machines — it has quietly transformed into one of the most dominant forces in agricultural technology.
  • At the intersection of artificial intelligence and farming, Deere is building a future where its equipment not only performs fieldwork but also interprets real-time data, automates decision-making, and boosts crop yields through precision.
  • The company’s recent developments, including strong second-quarter financials for fiscal 2025 and an impressive Investor Day presentation in Brazil, reveal a clear trajectory: Deere is shifting from traditional machinery to becoming a full-scale agri-tech platform.

Datadog Eyes $1 Billion Upwind Deal: Could This Be A Game-Changer For Cloud Security?

By Baptista Research

  • Datadog, a leader in observability and security, is reportedly in advanced talks to acquire Israeli cybersecurity firm Upwind for approximately $1 billion, according to a report by Calcalist.
  • The move comes just months after Upwind raised $100 million in a Series A funding round, valuing the startup at roughly $900 million.
  • As Datadog continues expanding its product portfolio, especially in cloud-native security and AI observability, the potential acquisition of Upwind signals a strategic push deeper into cloud workload protection and runtime security.

[Earnings Preview] Shell Falters on Fundamentals, But Options Data Signals Optimism

By Suhas Reddy

  • Shell’s Q2 2025 revenue is expected to drop 10.6% QoQ and 16.9% YoY. Its EPS is projected to drop 29.9% QoQ and 34.8% YoY.
  • Despite stronger refining margins, unplanned maintenance is expected to drag down downstream and chemicals earnings, pressuring overall performance.
  • However, options positioning reflects bullish sentiment, with traders betting on a potential upside surprise despite a downbeat operational update.

Dialogue. Evolution 2Q25 Business Update, Black Markets, UK Investigation, Asia Cyber Attacks

By The Synopsis

  • Evolution reported 2Q25 earnings, with stock up 7% on the day
  • Live casino revenue up 4%, RNG flat with potential for growth
  • Expansion of partnership with Hasbro for Monopoly IP in North America, positive outlook in the market

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: StubWorld: CKH (1 HK) – Expect Near-Term Weakness If Exclusivity Ends Without Resolution and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • StubWorld: CKH (1 HK) – Expect Near-Term Weakness If Exclusivity Ends Without Resolution
  • Fraser Hospitality Trust (FHT SP): Scheme Vote on 15 August
  • Everything to Know About the Year-End CGT-Driven Retail Sell-Off & KOSPI Basis Move
  • Event Driven: Tilaknagar Ind ₹4,150 Cr Imperial Blue Acq.~Transformational Play or Leverage Trap?
  • [Japan M&A] Nikkei Reports Pacific Industrial (7250) To Go Private Via MBO at ¥110bn
  • Frasers Hospitality Trust (FHT SP): 15th August Vote On Frasers Prop/TCC Offer
  • Event Driven: Natco Pharma’s Strategic Acquisition of Adcock Ingram


StubWorld: CKH (1 HK) – Expect Near-Term Weakness If Exclusivity Ends Without Resolution

By David Blennerhassett

  • CK Hutchison Holdings (1 HK)‘s delicate dance continues as it juggles U.S and Beijing politics; and its fiduciary duty to shareholders, as the Blackrock exclusivity long stop date looms.
  • In a double dose of StubWorld this week, preceding my comments on CKH – and CK Infrastructure Holdings (1038 HK) – are the current setup/unwind tables for Asia-Pacific Holdcos.
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Fraser Hospitality Trust (FHT SP): Scheme Vote on 15 August

By Arun George

  • The Frasers Hospitality Trust (FHT SP) IFA opines that Frasers Property Ltd (FPL SP)’s scheme offer of S$0.71 cash and permitted distributions (estimated at S$0.0098) is fair and reasonable.
  • While the current offer is arguably light compared to the failed 2022 offer, the lack of vocal opposition and limited retail displeasure reduces the vote risk.
  • On balance, the scheme vote should pass. For a 30 September payment, the gross/annualised spread of the total offer (S$0.7198) is 2.8%/15.6%.  

Everything to Know About the Year-End CGT-Driven Retail Sell-Off & KOSPI Basis Move

By Sanghyun Park

  • If the CGT threshold drops from ₩5B to ₩1B, year-end retail selling could surge—net sales were ₩14T in Nov–Dec 2023 versus just ₩2.5T in the same period of 2024.
  • Retail may react strongly this year due to higher unrealized gains and the ₩1B CGT threshold return; about 65% of KOSPI stocks still use year-end dividend record dates.
  • Odds are high for a classic year-end CGT-driven retail sell-off and a sharp KOSPI cash-futures basis move, fueled by dividend uncertainty we can capitalize on.

Event Driven: Tilaknagar Ind ₹4,150 Cr Imperial Blue Acq.~Transformational Play or Leverage Trap?

By Nimish Maheshwari

  • Tilaknagar Industries (TLNGR IN) acquires Pernod Ricard India’s Imperial Blue for INR 4,150 crore, diversifying its portfolio into whisky from dominance in brandy.
  • This acquisition will establish TI as a pan-India spirits player, significantly enhancing distribution and is expected to be accretive.
  • However, substantial deal size raises concerns about equity dilution, high leverage risks, and significant integration challenges for TI

[Japan M&A] Nikkei Reports Pacific Industrial (7250) To Go Private Via MBO at ¥110bn

By Travis Lundy

  • Overnight, the Nikkei carried an article saying Toyota valve supplier Pacific Industrial (7250 JP) would go private at a 40% premium in an MBO. 
  • The implied price would match its ATH, but would remain far below book value, which is disappointing for a company with a very strong customer base and market share.
  • This is potentially blockable, but it would need to be activism from scratch I think. An activist or collection of them would need about 18-20% to block this deal.

Frasers Hospitality Trust (FHT SP): 15th August Vote On Frasers Prop/TCC Offer

By David Blennerhassett

  • Back on the 14th May 2025, S-REIT Frasers Hospitality Trust (FHT SP) entered into a Scheme with its current sponsor, Frasers Property Limited, @ S$0.71/share.
  • The Scheme Consideration is 1.11x the latest adjusted NAV estimate of S$0.63904/unit; and S$0.01/unit above Frasers/TCC’s S$0.70/unit failed Offer back in September 2022.
  • The Scheme Doc is now out, with a shareholder vote on the 13th August. The IFA says fair and reasonable. 

Event Driven: Natco Pharma’s Strategic Acquisition of Adcock Ingram

By Nimish Maheshwari

  • Natco Pharma acquires a 35.75% stake in South Africa’s Adcock Ingram, marking its largest overseas expansion to date.
  • This move instantly gives Natco a strong foothold in Africa’s pharma market and diversifies its global revenue streams from current headwind of US market.
  • Natco transitions from a primarily India/US-focused player to a serious contender in strategic emerging markets, enhancing its growth outlook.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: REA Group Ltd, Fisher & Paykel Healthcare Cor, Macquarie Group, Sigma Healthcare, Coles Group , Bellevue Gold and more

By | Australia, Daily Briefs

In today’s briefing:

  • Quiddity Leaderboard ASX Sep25: Exp ADDs Down Vs Exp DELs Since Methodology Change; Time to Reverse?
  • Fisher & Paykel Healthcare (FPH AU) Vs. ResMed (RMD AU): Dislocation in Healthcare
  • Macquarie Group Ltd – The Overnight Report: AI Fuels New Highs
  • Rudi’s View: Bega Cheese, Cettire, Harvey Norman, Sigma, SiteMinder & More
  • Coles Group Limited: Initiation of Coverage- Next-Level Efficiency & Data-Driven Retail Tactics Poised to Shake Up the Sector!
  • Bellevue Gold Ltd – In Case You Missed It – BC Extra Upgrades & Downgrades – 25-07-25


Quiddity Leaderboard ASX Sep25: Exp ADDs Down Vs Exp DELs Since Methodology Change; Time to Reverse?

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the potential index changes for ASX 300, 200, 100, 50, and 20 in the run-up to the September 2025 index rebal event.
  • Currently, a market consultation is being conducted and there could be several significant changes made to the index selection process.
  • The official index changes will be announced after the close on Friday 5th September 2025.

Fisher & Paykel Healthcare (FPH AU) Vs. ResMed (RMD AU): Dislocation in Healthcare

By Gaudenz Schneider

  • Context: The Fisher & Paykel Healthcare (FPH AU) vs. ResMed (RMD AU) Price-Ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: The long position is supported by higher growth aligning well with the statistical analysis. The trade faces some event risk due to an upcoming earnings announcement.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Macquarie Group Ltd – The Overnight Report: AI Fuels New Highs

By FNArena

  • The AI trade took the S&P500 and Nasdaq to new highs (again) with markets in Japan and Europe rallying also.
  • The Australian market stumbled on Governor Bullock’s hawish tone yesterday.
  • ASX200 futures are pointing to another day of net weakness.

Rudi’s View: Bega Cheese, Cettire, Harvey Norman, Sigma, SiteMinder & More

By FNArena

  • In today’s edition: -Ask FNArena -Review All-Weather Model Portfolio -Recent Updates On Expert Views -Best Buys & Conviction Calls

Coles Group Limited: Initiation of Coverage- Next-Level Efficiency & Data-Driven Retail Tactics Poised to Shake Up the Sector!

By Baptista Research

  • The Coles Group’s financial results for the first half of fiscal year 2025 present a mixed picture of robust revenue growth and cost management challenges.
  • The company reported a 3.7% increase in group sales revenue, reaching over $23 billion.
  • This growth was bolstered by their strategic focus on core business execution, value campaigns, and strong seasonal trade during events like Christmas and Halloween.

Bellevue Gold Ltd – In Case You Missed It – BC Extra Upgrades & Downgrades – 25-07-25

By FNArena

  • A summary of the highlights from Broker Call Extra updates throughout the week past.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: ECB: Watching the Good Place and more

By | Daily Briefs, Macro

In today’s briefing:

  • ECB: Watching the Good Place
  • China Economics: Has China Escaped Its Housing-Consumption Slump Yet?
  • CX Daily: Sinovac’s Covid Fortune Fuels Bitter Boardroom Battle
  • New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum’s Spike, MicroStrat…


ECB: Watching the Good Place

By Phil Rush

  • The ECB kept its description of the policy setting as in a good place, and wants to watch the news in the next few months. Lagarde refused to emphasise September’s meeting.
  • Euro strength is depressing inflation below target in the near-term forecasts, but the ECB remains relaxed about this. It sees the outlook as broadly unchanged since June.
  • We still see rolling resilience in the economy and doubt US trade policy will break it. More rate cuts are inappropriate without demand destruction, so we don’t expect any.

China Economics: Has China Escaped Its Housing-Consumption Slump Yet?

By Manu Bhaskaran

  • China’s economic malaise will not end until its housing market clears and households have sufficiently rebuilt their savings. These adjustments are far from complete. 
  • Continued declines in housing prices across major and smaller urban areas suggest that prices have further to fall, while housing demand and supply are still sluggish. 
  • Households also remain defensive, with deposit growth outstripping income growth by a large margin. The economic headwinds will entrench precautionary savings behaviour.

CX Daily: Sinovac’s Covid Fortune Fuels Bitter Boardroom Battle

By Caixin Global

  • Sinovac / In Depth: Sinovac’s Covid fortune fuels bitter boardroom battle
  • Wahaha /Chinese beverage heir was an American citizen, U.S. tax records reveal
  • Visa /U.S. visa scrutiny pushes Chinese students to scrub their social media

New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum’s Spike, MicroStrat…

By William Mann

  • Podcast has been running for almost seven months with recent guest episodes
  • Discussion on recent global asset trends and market news, including inflation, Fed rate cuts, and Trump’s tariff threats
  • Mention of interns from CUNY City Tech helping with macro database analysis and highlighting Ethereum’s strong performance in the market.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Tesla , Corpay, Palo Alto Networks, McGraw Hill, Datadog , Deere & Co, Shell , Shoulder Innovations, Accelerant Holdings, Intel Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • Tesla (TSLA): Go Short
  • Corpay’s $2.2 Billion Move: Why The Alpha Group Deal Could Be A Game-Changer For Global B2B Payments
  • Palo Alto Eyes SentinelOne: The $7 Billion Power Move That Could Reshape Cybersecurity!
  • McGraw Hill, Inc. (MH): Another Private Equity Backed IPO Trades Below Issue, Closes Flat
  • Datadog Eyes $1 Billion Upwind Deal: Could This Be A Game-Changer For Cloud Security?
  • Deere & Co Is Quietly Dominating the AI Farming Revolution—Here’s Why It Could Be The TESLA Of Agriculture!
  • [Earnings Preview] Shell Falters on Fundamentals, But Options Data Signals Optimism
  • Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO
  • Accelerant Holdings (ARX): Insurance Sector Brings Another IPO Winner to Market; Pops 36% at Open
  • Intel 2Q25: Getting Worse. Excluding Restructuring Charges, GM Miss by 700bps, Non-GAAP OP Negative.


Tesla (TSLA): Go Short

By Henry Soediarko

  • Not impressive earnings result for 2Q25 as revenue fell 12%, led by a weaker EV sales followed by lower sales from the renewable energy division as well.  
  • The highest-margin business contributor, regulatory credit, may be gone soon as recently the US government removed the financial penalty for higher emissions. 
  • Tesla (TSLA US) is trading at premium compared to its Chinese counterparts such as BYD (1211 HK) , NIO (9866 HK) and XPeng (9868 HK) .

Corpay’s $2.2 Billion Move: Why The Alpha Group Deal Could Be A Game-Changer For Global B2B Payments

By Baptista Research

  • Corpay has made headlines with its definitive agreement to acquire Alpha Group International in an all-cash deal valued at approximately $2.2 billion (£1.6 billion).
  • The transaction, offering Alpha shareholders £42.50 per share—a 55% premium over its undisturbed price as of May 1, 2025—is expected to close in Q4 2025, pending shareholder and regulatory approvals.
  • This acquisition comes on the heels of a busy strategic year for Corpay, including a $300 million cross-border partnership with Mastercard and a minority investment in AvidXchange.

Palo Alto Eyes SentinelOne: The $7 Billion Power Move That Could Reshape Cybersecurity!

By Baptista Research

  • Rumors are swirling around a potential acquisition that could significantly reshape the cybersecurity landscape.
  • SentinelOne, a company known for its autonomous endpoint protection platform, saw its shares surge after reports emerged suggesting that industry giant Palo Alto Networks (NASDAQ: PANW) might be in advanced talks to acquire it.
  • While neither company has confirmed the speculation, multiple Israeli media outlets have cited industry sources suggesting a potential deal value of around $7 billion.

McGraw Hill, Inc. (MH): Another Private Equity Backed IPO Trades Below Issue, Closes Flat

By IPO Boutique

  • McGraw Hill (MH US) priced a full-size offering of 24.4mm shares at $17.00 and saw a flat opening print. 
  • This was the second private equity backed deal of the week and second to trade below issue.
  • Ultimately, the deal did not have the “strength” and was forced to give-way to the buy-side with a $2 discount below the low-end of the range.

Datadog Eyes $1 Billion Upwind Deal: Could This Be A Game-Changer For Cloud Security?

By Baptista Research

  • Datadog, a leader in observability and security, is reportedly in advanced talks to acquire Israeli cybersecurity firm Upwind for approximately $1 billion, according to a report by Calcalist.
  • The move comes just months after Upwind raised $100 million in a Series A funding round, valuing the startup at roughly $900 million.
  • As Datadog continues expanding its product portfolio, especially in cloud-native security and AI observability, the potential acquisition of Upwind signals a strategic push deeper into cloud workload protection and runtime security.

Deere & Co Is Quietly Dominating the AI Farming Revolution—Here’s Why It Could Be The TESLA Of Agriculture!

By Baptista Research

  • Deere & Co is no longer just a symbol of tractors and green machines — it has quietly transformed into one of the most dominant forces in agricultural technology.
  • At the intersection of artificial intelligence and farming, Deere is building a future where its equipment not only performs fieldwork but also interprets real-time data, automates decision-making, and boosts crop yields through precision.
  • The company’s recent developments, including strong second-quarter financials for fiscal 2025 and an impressive Investor Day presentation in Brazil, reveal a clear trajectory: Deere is shifting from traditional machinery to becoming a full-scale agri-tech platform.

[Earnings Preview] Shell Falters on Fundamentals, But Options Data Signals Optimism

By Suhas Reddy

  • Shell’s Q2 2025 revenue is expected to drop 10.6% QoQ and 16.9% YoY. Its EPS is projected to drop 29.9% QoQ and 34.8% YoY.
  • Despite stronger refining margins, unplanned maintenance is expected to drag down downstream and chemicals earnings, pressuring overall performance.
  • However, options positioning reflects bullish sentiment, with traders betting on a potential upside surprise despite a downbeat operational update.

Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO

By IPO Boutique

  • Shoulder Innovations will be offering 5.0mm shares at $19-$21 and to debut on July 31st.
  • The underwriters have reserved up to 6% of the shares of common stock offered through a directed share program. 
  • The sector had a surprise underperformance from CarlsMed this week and will be looking to rebound with this upcoming IPO. 

Accelerant Holdings (ARX): Insurance Sector Brings Another IPO Winner to Market; Pops 36% at Open

By IPO Boutique

  • Accelerant Holdings (ARX US)  priced 34.46mm shares (upsized from 28.95mm) at $21.00($1 Above the $18-$20 range) and opened at $28.50 for a gain of 35.7% at first trade.
  • This was the fifth insurance related IPO to debut in 2025 and all have been winners.
  • We see this company having potential staying power in the short term. Several insurance related IPOs have traded higher for longer than many short term investors would have anticipated.

Intel 2Q25: Getting Worse. Excluding Restructuring Charges, GM Miss by 700bps, Non-GAAP OP Negative.

By Nicolas Baratte

  • 2Q25 huge miss, even excluding restructuring costs. 3Q guidance is “back to normal” but how to put any trust in guidance after the 2Q miss? Better wait for 3Q earnings. 
  • Consensus will revised down sharply. 2025 definitely too high. 2027 expectations of a sharp margins improvement require a perfect alignment of the stars. 
  • New CEO who is cleaning up the organization and refocusing Intel on what is required: fixing manufacturing, regaining x86 market share. It’s a good start, but can take 2-3 years.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Korea Stock Exchange KOSPI 200, SKC Co Ltd, SK Hynix, Samsung Biologics and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Everything to Know About the Year-End CGT-Driven Retail Sell-Off & KOSPI Basis Move
  • Potential Adds & Deletes in a Major Global Index in August 2025 As Highlighted by Locals in Korea
  • SK Hynix: Good 2Q, Positive Messages but No 2026 Guidance Means that Market’s Doubts Will Remain
  • Samsung Biologics (207940 KS): Bumps up Full Year Guidance Amid Strong 2Q Show and Plant 4 Ramp-Up


Everything to Know About the Year-End CGT-Driven Retail Sell-Off & KOSPI Basis Move

By Sanghyun Park

  • If the CGT threshold drops from ₩5B to ₩1B, year-end retail selling could surge—net sales were ₩14T in Nov–Dec 2023 versus just ₩2.5T in the same period of 2024.
  • Retail may react strongly this year due to higher unrealized gains and the ₩1B CGT threshold return; about 65% of KOSPI stocks still use year-end dividend record dates.
  • Odds are high for a classic year-end CGT-driven retail sell-off and a sharp KOSPI cash-futures basis move, fueled by dividend uncertainty we can capitalize on.

Potential Adds & Deletes in a Major Global Index in August 2025 As Highlighted by Locals in Korea

By Douglas Kim

  • In this insight, we discuss the potential adds and deletes of Korean stocks in a major global index in August 2025 as highlighted by the locals in Korea. 
  • There are about 10 potential additions to the major global index mentioned by various local media accounts. LIG Nex1, Hyosung Heavy Industries, and Doosan Corp are most likely inclusion candidates. 
  • There have been three companies that have been consistently mentioned in numerous local media as potential deletion candidates including LG Innotek, CJ Cheiljedang, and SKC Co. 

SK Hynix: Good 2Q, Positive Messages but No 2026 Guidance Means that Market’s Doubts Will Remain

By Nicolas Baratte

  • 2Q25 beats consensus by 5% with a number of unexpected moves: NAND and Commodity DRAM shipments a lot higher than expected, hence weaker ASP (more commodity), margins decline QoQ. 
  • HBM positive messages: HBM sales double in 2025, we now have secured visibility on next year’s demand”, leading to higher capex in 2025, HBM will continue to enjoy strong growth. 
  • But a lack of concrete numbers (HBM, eSSD % of revenue), 2025-26 Capex, capacity increase, etc means that the market will not find grounds to have a more positive view. 

Samsung Biologics (207940 KS): Bumps up Full Year Guidance Amid Strong 2Q Show and Plant 4 Ramp-Up

By Tina Banerjee

  • Samsung Biologics (207940 KS) maintained positive momentum in 2Q25, with consolidated revenue and operating profit rising 11% and 9%, YoY, respectively. 
  • Leveraging on strong 2Q result and successful ramp-up of Plant 4 providing additional momentum, the company has revised annual revenue growth guidance upward to 25–30% YoY from 20–25%.
  • Going ahead, the company is planning to shed its biosimilars subsidiary, Samsung Bioepis, to “focus on strengthening its core capabilities as a pure-play CDMO.”

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: Frasers Hospitality Trust, QAF Ltd and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Fraser Hospitality Trust (FHT SP): Scheme Vote on 15 August
  • QAF: Regional Consumer Stock with Appealing 5.6% Dividend Yield
  • Frasers Hospitality Trust (FHT SP): 15th August Vote On Frasers Prop/TCC Offer


Fraser Hospitality Trust (FHT SP): Scheme Vote on 15 August

By Arun George

  • The Frasers Hospitality Trust (FHT SP) IFA opines that Frasers Property Ltd (FPL SP)’s scheme offer of S$0.71 cash and permitted distributions (estimated at S$0.0098) is fair and reasonable.
  • While the current offer is arguably light compared to the failed 2022 offer, the lack of vocal opposition and limited retail displeasure reduces the vote risk.
  • On balance, the scheme vote should pass. For a 30 September payment, the gross/annualised spread of the total offer (S$0.7198) is 2.8%/15.6%.  

QAF: Regional Consumer Stock with Appealing 5.6% Dividend Yield

By Punit Khanna

  • Singapore small-mid cap stocks are having a good run in anticipation of Market Equity Development Programme. QAF may appeal to yield investors
  • QAF is a well run number 1 bread company in Singapore, Malaysia and Philippines
  • Business is stable and mature making it difficult for a new player to enter the market

Frasers Hospitality Trust (FHT SP): 15th August Vote On Frasers Prop/TCC Offer

By David Blennerhassett

  • Back on the 14th May 2025, S-REIT Frasers Hospitality Trust (FHT SP) entered into a Scheme with its current sponsor, Frasers Property Limited, @ S$0.71/share.
  • The Scheme Consideration is 1.11x the latest adjusted NAV estimate of S$0.63904/unit; and S$0.01/unit above Frasers/TCC’s S$0.70/unit failed Offer back in September 2022.
  • The Scheme Doc is now out, with a shareholder vote on the 13th August. The IFA says fair and reasonable. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Tilaknagar Industries, Indian Energy Exchange Ltd, Natco Pharma, Brigade Hotel Ventures Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Event Driven: Tilaknagar Ind ₹4,150 Cr Imperial Blue Acq.~Transformational Play or Leverage Trap?
  • India’s Energy Exchanges: Market Coupling, the Next Big Disruption
  • Event Driven: Natco Pharma’s Strategic Acquisition of Adcock Ingram
  • Brigade Hotel IPO: Not Suited for a Long Term Stay for Now, Can Try For a Quick Day Trip Gain
  • Market Coupling Mandate: Structural Risk or Opportunity Reset for IEX (NSE: IEX, BSE: 540750)?


Event Driven: Tilaknagar Ind ₹4,150 Cr Imperial Blue Acq.~Transformational Play or Leverage Trap?

By Nimish Maheshwari

  • Tilaknagar Industries (TLNGR IN) acquires Pernod Ricard India’s Imperial Blue for INR 4,150 crore, diversifying its portfolio into whisky from dominance in brandy.
  • This acquisition will establish TI as a pan-India spirits player, significantly enhancing distribution and is expected to be accretive.
  • However, substantial deal size raises concerns about equity dilution, high leverage risks, and significant integration challenges for TI

India’s Energy Exchanges: Market Coupling, the Next Big Disruption

By Sudarshan Bhandari

  • India’s CERC has approved the implementation of Market Coupling in the DAM(Day Ahead Market)  by Jan-26, with Real Time Market (RTM) coupling to follow after operational experience is gained.
  • IEX currently commands 99.8% market share in both DAM and RTM. With MC, price discovery will be centralized, eroding IEX’s platform advantage and likely resulting in loss of market share.
  • If MC had been implemented in FY25, IEX’s earnings would have been 20% lower. This regulatory shift poses a clear structural risk to IEX’s volume dominance and earnings growth.

Event Driven: Natco Pharma’s Strategic Acquisition of Adcock Ingram

By Nimish Maheshwari

  • Natco Pharma acquires a 35.75% stake in South Africa’s Adcock Ingram, marking its largest overseas expansion to date.
  • This move instantly gives Natco a strong foothold in Africa’s pharma market and diversifies its global revenue streams from current headwind of US market.
  • Natco transitions from a primarily India/US-focused player to a serious contender in strategic emerging markets, enhancing its growth outlook.

Brigade Hotel IPO: Not Suited for a Long Term Stay for Now, Can Try For a Quick Day Trip Gain

By Tina Banerjee

  • Brigade Hotel Ventures has filed for IPO to raise up to INR 7,596M. The company plans to sell 84.4M shares at between INR 85 and INR 90 per share.
  • The company owns and develops hotels in key cities in India, with a portfolio of nine operating hotels. The hotels are operated by global marquee hospitality companies.
  • The debt-to-equity ratio for Brigade Hotel being at 5.8x is the highest among its peers. The company’s plans to use the proceeds to service the outstanding debts makes sense.

Market Coupling Mandate: Structural Risk or Opportunity Reset for IEX (NSE: IEX, BSE: 540750)?

By Rahul Jain

  • CERC has mandated market coupling for the Day-Ahead Market starting Jan 2026, shifting price discovery to a central engine.
  • This dilutes IEX’s pricing power but core execution role, user trust, and market share offer downside protection.
  • Valuations at 38–40× FY25 EPS imply a fair value range of Rs175–195, with upside if growth in green and RTM segments accelerates.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars